Nabumetone detailed information

Revision as of 18:15, 27 September 2011 by WikiBot (talk | contribs) (Protected "Nabumetone detailed information": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Nabumetone detailed information
File:Nabumetone.svg
Clinical data
Routes of
administration
Oral
ATC code
Pharmacokinetic data
Protein binding> 99% (active metabolite)
MetabolismHepatic, to active metabolite 6-methoxy-2-naphthylacetic acid
Elimination half-life23 hours (active metabolite)
ExcretionRenal
Identifiers
CAS Number
PubChem CID
DrugBank
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC15H16O2
Molar mass228.29 g/mol

Nabumetone is a non-steroidal anti-inflammatory drug of the arylalkanoic acid family (which includes diclofenac). Marketed under the brand name Relafen, it has been shown to have a slightly lower risk of gastrointestinal side effects than most other non-selective NSAID's.

Template:Pharma-stub

de:Nabumeton Template:WikiDoc Sources